Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/250627
Share/Export:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Title

Nanotechnology-Based Platforms for Vaginal Delivery of Peptide Microbicides

AuthorsSánchez-López, Elena; Gómara Elena, María José CSIC ORCID; Haro Villar, Isabel CSIC ORCID
KeywordsVaginal microbicides
Nanoparticles
Antimicrobial peptides
STD
Vaginal drug delivery
Polymeric nanoparticles
Lipid vesicles
Sexually transmitted infections
Issue DateJul-2021
PublisherBentham Science Publishers
CitationCurrent Medicinal Chemistry 28 (22) (2021)
AbstractBackground: Vaginal drug delivery offers an opportunity for effective microbicide treatments. However, the physiological characteristics of the vagina represent a challenge when preparing microbicide formulations for local delivery that avoid systemic effects. Objective: To review recent advances in vaginal microbicides placing special emphasis on nanocarriers that encapsulate peptide microbicides. The review includes an overview of local treatment and prevention strategies for bactericidal, fungal, protozoal and viral vaginal infections that use peptide microbicides. Methods: Scientific literature and clinical trials published in the PubMed database since 2015 are analyzed. Result: Peptide microbicides are used for vaginal drug delivery as a means of prevention and treatment of several infectious diseases, especially sexually transmitted infections, and it is clear that such peptide-based microbicides constitute a suitable strategy. Their combination with nanotechnological drug delivery systems improves local peptide administration while avoiding their degradation and adverse effects. To date, only a few polymeric and lipid-based nanocarriers have been used for peptide microbicide vaginal delivery. Conclusion: The combination of nanotechnology and peptide microbicides has emerged over recent years, and different platforms are being used for vaginal peptide delivery. Nanostructured systems for peptide delivery via vaginal rings or hydrogels are increasingly used as platforms capable of providing suitable drug delivery. However, there is still a lack of knowledge about nanocarriers aimed at encapsulating peptides for local microbicide delivery.
Publisher version (URL)10.2174/0929867328666201209095753
URIhttp://hdl.handle.net/10261/250627
DOI10.2174/0929867328666201209095753
Appears in Collections:(IQAC) Artículos

Files in This Item:
File Description SizeFormat Existing users please Login
BMS-CMC-2020-359.pdfArtículo principal833,77 kBAdobe PDFEmbargoed until July 1, 2022    Request a copy
Show full item record
Review this work

WEB OF SCIENCETM
Citations

1
checked on Nov 23, 2021

Google ScholarTM

Check

Altmetric

Dimensions


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.